2013 Q3/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +1 Idenix Pharmaceuticals
8.3
2 +1 Kyowa Hakko Kirin UK
7.9
3 +49 Wockhardt
7.8
4 +0 Renovo
7.2
5 +0 Mylan UK
7.2
6 +31 EISAI UK
7.2
7 -6 Galenica AG
7.2
8 +5 Debiopharm
7.1
9 +6 Genmab
7.1
10 +0 Kyorin Holdings
7.0
11 -4 Biotecnol
7.0
12 +9 Servier UK
6.8
13 +12 Actelion UK
6.7
14 -8 Aptalis Pharma
6.7
15 -7 Kaken Pharmaceutical
6.6
16 +164 ImmunoGen
6.5
17 -8 Vectura
6.4
18 +1 Lilly UK
6.3
19 -7 Questcor
6.3
20 +94 Auxilium Pharmaceuticals
6.2
21 -4 Actelion
6.1
22 -8 Meda Pharmaceuticals
6.1
23 -12 Yakult UK
6.0
24 -8 KRKA
5.9
25 -5 Otsuka Pharmaceuticals Europe
5.8
26 +0 EISAI
5.7
27 +4 Pfizer UK
5.3
28 -6 AEterna Zentaris
5.3
29 +15 Otsuka Pharmaceuticals
5.3
30 +25 Astrazeneca Uk
5.3
31 +5 Recordati
5.2
32 +1 Dusa Pharmaceuticals
5.2
33 -1 Galapagos
5.2
34 +22 Wockhardt UK
5.2
35 -5 Taisho Pharmaceutical
5.1
36 -1 Astellas Europe
5.1
37 +1 Stallergenes
5.0
38 +27 Santen
5.0
39 +1 Sanofi UK
5.0
40 +30 Daiichi-Sankyo UK
5.0
41 +58 Teva Pharmaceutical Industries Ltd
4.9
42 +118 MediGene
4.9
43 +19 Valeant Pharmaceuticals
4.9
44 +20 Pharmstandard
4.8
45 -17 Stada
4.8
46 +0 Covence
4.8
47 -20 Zandu
4.8
48 -7 Dainippon Sumitomo
4.8
49 +8 Nippon Kayaku
4.8
50 +23 Nektar Therapeutics
4.8


Changes in rank are compared to 2013 Q2/Global Life Sciences. Since then, 3 sites entered the survey and 50 sites could not be included in the rankings (3 more since last time). Build your own. Report statistics.